Results 251 to 260 of about 39,480 (265)

BEANS—A SOURCE OF L-DOPA

The Lancet, 1969
openaire   +2 more sources

l-DOPA Cyclohexyl Ester Is a Novel Potent and Relatively Stable Competitive Antagonist Against l-DOPA Among Several l-DOPA Ester Compounds

The Japanese Journal of Pharmacology, 2000
Yoshio Goshima, Takeaki Miyamae, Kiyohide Fujita   +2 more
exaly  

L-DOPA AND OCULOGYRIC CRISES

The Lancet, 1970
O W, Sacks, M, Kohl
openaire   +2 more sources

Dopaminergic modulation of cognitive function-implications for l-DOPA treatment in Parkinson's disease

Neuroscience and Biobehavioral Reviews, 2006
Roshan Cools
exaly  

Dopa-decarboxylase gene polymorphisms affect the motor response to l-dopa in Parkinson's disease

Parkinsonism and Related Disorders, 2014
Jean-Christophe Corvol, Marie Vidailhet, David Devos   +2 more
exaly  

Side Effects of L-Dopa

New England Journal of Medicine, 1971
D S, Sax, D, Tarsy
openaire   +2 more sources

COMBINED TREATMENT OF PARKINSONISM WITH L-DOPA AND AMANTADINE

Lancet, The, 1970
R B Godwin-Austen, J D Parkes
exaly  

L Dopa

2007
openaire   +1 more source

Evidence for L-dopa incorporation into cell proteins in patients treated with levodopa

Journal of Neurochemistry, 2006
Kenneth Rodgers, Roger T Dean, John G L Morris   +2 more
exaly  

Striatal L-DOPA Decarboxylase Activity in Parkinson's Disease In Vivo: Implications for the Regulation of Dopamine Synthesis

Journal of Neurochemistry, 1993
Gabriel C Leger, Paul Cumming, Albert Gjedde   +2 more
exaly